Gts Securities LLC Siga Technologies Inc Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$6.74 - $11.97 $12,806 - $22,743	-1,900 Reduced 4.45%	40,800 $274,000
Q2 2024 Aug 14, 2024	BUY	$6.32 - $10.46 $155,472 - $257,316	24,600 Added 135.91%	42,700 $324,000
Q1 2024 May 15, 2024	BUY	$4.51 - $8.92 $34,727 - $68,684	7,700 Added 74.04%	18,100 $154,000
Q4 2023 Feb 14, 2024	SELL	$4.82 - $6.25 $12,050 - $15,625	-2,500 Reduced 19.38%	10,400 $58,000
Q3 2023 Nov 15, 2023	BUY	$4.32 - $5.77 $55,728 - $74,433	12,900 New	12,900 $67,000

184

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $434M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.